Alterations of retinal pigment epithelium cause AMD-like retinopathy in senescent-accelerated OXYS rats

Aging

Volumn 3, Issue 1, 2011, Pages 44-54

  Markovets, Anton M ^a   Saprunova, Valeriya B ^b   Zhdankina, Anna A ^c   Fursova, Anzhella Zh ^a   Bakeeva, Lora E ^b   Kolosova, Natalia G ^a,b  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c SIBERIAN STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Age related macular degeneration; Molecular mechanism of pathogenesis; OXYS rats; Pigment epithelium derived factor; Vascular endothelial growth factor

Indexed keywords

EYE PROTEIN; NERVE GROWTH FACTOR; PIGMENT EPITHELIUM DERIVED FACTOR; PIGMENT EPITHELIUM-DERIVED FACTOR; SERINE PROTEINASE INHIBITOR; VASCULOTROPIN A;

AGING; ANIMAL; ARTICLE; GENE EXPRESSION; GENETICS; HUMAN; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PIGMENT EPITHELIUM; RAT; RAT STRAIN; RETINA; RETINA MACULA DEGENERATION; ULTRASTRUCTURE; WISTAR RAT;

AGING; ANIMALS; EYE PROTEINS; GENE EXPRESSION; HUMANS; MACULAR DEGENERATION; MALE; NERVE GROWTH FACTORS; RATS; RATS, INBRED STRAINS; RATS, WISTAR; RETINA; RETINAL PIGMENT EPITHELIUM; SERPINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79958253721     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100243     Document Type: Article

References (43)

1. Strauss O. The retinal pigment epithelium in visual function. Physiol Rev. 2005; 85: 845-881.
2. Strunnikova NV, Maminishkis A, Barb JJ, Wang F, Zhi C, Sergeev Y, Chen W, Edwards AO, Stambolian D, Abecasis G, Swaroop A, Munson PJ, Miller SS. Transcriptome analysis and molecular signature of human retinal pigment epithelium. Hum Mol Genet. 2010; 19: 2468-2486.
3. Korte GE, Gerszberg T, Pua F, Henkind P. Choriocapillaris atrophy after experimental destruction of the retinal pigment epithelium in the rat. A study in thin sections and vascular casts. Acta Anat (Basel). 1986; 127: 171-175.
4. McLeod DS, Grebe R, Bhutto I, Merges C, Baba T, Lutty GA. Re lationship between RPE and choriocapillaris in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2009; 50: 4982-4991.
5. Tombran-Tink J, Shivaram SM, Chader GJ, Johnson LV, Bok D. Expression, secretion, and age-related downregulation of pigment epithelium-derived factor, a serpin with neurotrophic activity. J Neurosci. 1995; 15: 4992-5003.
6. Perez-Mediavilla LA, Chew C, Campochiaro PA, Nickells RW, Notario V, Zack DJ, Becerra SP. Sequence and expression analysis of bovine pigment epithelium-derived factor. Biochim Biophys Acta. 1998; 1398: 203-214.
7. Blaauwgeers HG, Holtkamp GM, Rutten H, Witmer AN, Koolwijk P, TA, Alitalo K, Kroon ME, Kijlstra A, van Hinsbergh VW, Schlingemann RO. Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. Am J Pathol. 1999; 155: 421-428.
8. Witmer AN, Dai J, Weich HA, Vrensen GF, Schlingemann RO. Expression of vascular endothelial growth factor receptors 1, 2, and 3 in quiescent endothelia. J Histochem Cytochem. 2002; 50: 767-777.
9. Ferrara N, Gerber H, LeCouter J. The biology of VEGF and its receptor. Nat Med. 2003; 9: 669-676.
10. Grisanti S and Tatar O. The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration. Prog Retin Eye Res. 2008; 27: 372-390.
11. Tsai DC, Charng MJ, Lee FL, Hsu WM, Chen SJ. Different plasma levels of vascular endothelial growth factor and nitric oxide between patients with choroidal and retinal neovascularization. Ophthalmologica. 2006; 220: 246-251.
12. Spilsbury K, Garrett KL, Shen WY, Constable IJ, Rakoczy PE. Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. Am. J. Pathol. 2000; 157: 135-144.
13. Wang B, Atherton P, Patel R, Manning G, Donnelly R. Antiangiogenic effects and transcriptional regulation of pigment epithelium-derived factor in diabetic retinopathy. Microvasc Res. 2010; 80: 31-36.
14. Wolf S. Current status of anti-vascular endothelial growth factor therapy in Europe. Jpn J Ophthalmol. 2008; 52: 433-439.
15. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science. 1999; 285: 245-248.
16. Tong JP and Yao YF. Contribution of VEGF and PEDF to choroidal angiogenesis: a need for balanced expressions. Clin Biochem. 2006; 39: 267-276.
17. Filleur S, Nelius T, de Riese W, Kennedy RC. Characterization of PEDF: a multi-functional serpin family protein. J Cell Biochem. 2009; 106: 769-775.
18. Bhutto IA, McLeod DS, Hasegawa T, Kim SY, Merges C, Tong P, Lutty GA. Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp Eye Res. 2006; 82: 99-110.
19. Zhang SX, Wang JJ, Gao G, Parke K, Ma JX. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy. J Mol Endocrinol. 2006; 37: 1-12.
20. Kondo N, Honda S, Kuno S, Negi A. Positive association of common variants in CD36 with neovascular age-related macular degeneration. Aging. 2009; 1: 266-274
21. Kolosova NG, Lebedev PA, Aidagulova SV, Morozkova TS. OXYS rats as a model of senile cataract. Bull Exp Biol Med. 2003; 136: 415-419.
22. Zhdankina A, Fursova AZH, Logvinov SV, Kolosova NG. Clinical and Morphological Characteristicsof Chorioretinal Degeneration in Early Aging OXYS Rats. Bull Exp Biol Med. 2008; 146: 455-458.
23. Neroev VV, Archipova MM, Bakeeva LE, Fursova AZH, Grigorian EN, Grishanova AY, Iomdina EN, Ivashchenko ZhN, Katargina LA, Khoroshilova-Maslova IP, Kilina OV, Kolosova NG, et al. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 4. Age-related eye disease. SkQ1 returns vision to blind animals. Biochemistry (Mosc). 2008; 73: 1317-1328.
24. Saprunova VB, Pilipenko DI, Alexeevsky AV, Fursova AZH, Kolosovs NG, Bakeeva LE. Lipofuscin granule dynamics during the development of age-related macular degeneration. Biochemistry (Mosc). 2010; 75: 130-138.
25. X, Patel M, Chan C. Molecular pathology of age-related macular degeneration. Prog Retin Eye Res. 2009; 28: 1-18.
26. Bonilha VL. Age and disease-related structural changes in the retinal pigment epithelium. Clin Ophthalmol. 2008; 2: 413-424.
27. Steinle JJ, Sharma S, Chin VC. Normal aging involves altered expression of growth factors in the rat choroid. J Gerontol A Biol Sci Med Sci. 2008; 63: 135-140.
28. Ehrlich R, Harris A, Kheradiya NS, Winston DM, Ciulla TA, Wirostko B. Age-related macular degeneration and the aging eye. Clin Interv Aging. 2008; 3: 473-482.
29. Sonoda S, Sreekumar PG, Kase S, Spee C, Ryan SJ, Kannan R, Hinton DR. Attainment of polarity promotes growth factor secretion by retinal pigment epithelial cells: Relevance to agerelated macular degeneration. Aging. 2010; 2: 28-42.
30. Ohno-Matsui K, Yoshida T, Uetama T, Mochizuki M, Morita I. Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells. Biochem Biophys Res Commun. 2003; 303: 962-967.
31. Takenaka K, Yamagishi S, Jinnouchi Y, Nakamura K, Matsui T, Imaizumi T. Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells. Life Sci. 2005; 77: 3231-3241.
32. Zhu DH, Deng X, Xu J, Hinton DR. What determines the switch between atrophic and neovascular forms of age related macular degeneration? - the role of BMP4 induced senescence. Aging. 2009; 1: 740-745.
33. Zhu D, Wu J, Spee C, Ryan SJ, Hinton DR. BMP4 mediates oxidative stress-induced retinal pigment epithelial cell senescence and is overexpressed in age-related macular degeneration. J Biol Chem. 2009; 284: 9529-9539.
34. He Y and Tombran-Tink J. Mitochondrial Decay and Impairment of Antioxidant Defenses in Aging RPE Cells. Adv Exp Med Biol. 2010; 664: 165-183.
35. Jarrett SG, Lin H, Godley BF, Boulton ME. Mitochondrial DNA damage and its potential role in retinal degeneration. Prog Retin Eye Res. 2008; 27: 596-607.
36. Feher J, Kovacs I, Artico M, Cavallotti C, Papale A, Balacco Gabrieli C. Mitochondrial alterations of retinal pigment epithelium in age-related macular degeneration. Neurobiol Aging. 2006; 27: 983-993.
37. Sergeeva S, Bagryanskaya E, Korbolina E, Kolosova N. Development of behavioural dysfunctions in acceleratedsenescence OXYS rats is associated with early postnatal alterations in brain phosphate metabolism. Exp Gerontol. 2006; 41: 141-150.
38. Fursova AZH, Gusarevich OG, Gonchar AM, Kolosova NG. Experience of application of bilberry preparation for treatment of central chorioretinal degeneration. Bulletin of the SB RAMS. 2007;1: 92-96
39. Solovyeva NA, Morozkova TS, Salganik RI. Development of a rat subline with symptoms of hereditary galactosemia and study of its biochemical characteristics. Genetika. 1975;11: 63-71.
40. Obukhova LA, Skulachev VP, Kolosova NG. Mitochondriatargeted antioxidant SkQ1 inhibits age-dependent involution of the thymus in normal and senescence-prone rats. Aging. 2009; 1: 389-401.
41. Rat genome database: http://rgd.mcw.edu.
42. Reynolds E. The use of lead citrate at high pH as an electronopaque stain in electron microscopy. J Cell Biol. 1963;17:208- 212.
43. Nolan T, Hands RE, Bustin SA. Quantification of mRNA using real-time RT-PCR. Nat Protoc. 2006;1: 1559-1582.